Daily Stock Ratings & Price Targets
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €200 | ― | 25.50% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €11.5→€10.5 | ― | 5.10% | Assigned | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €86.1 | ― | 22.20% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €30 | ― | 3.10% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €185→€182 | ― | 3.60% | Reiterated | ||||
 | AIR France KLM | HOLD €9.6→€9.4 | ― | -5.10% | Reiterated | Morgan Stanley Reaffirms Their Hold Rating on AIR France KLM (0LN7) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €226 | ― | 21.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €47 | ― | 14.80% | Reiterated | ||||
| Arkema | SELL €43.51 | ― | -13.60% | Assigned | Barclays Reaffirms Their Sell Rating on Arkema (0IB0) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €170.61 | ― | 9.70% | Assigned | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €15.36→€14.5 | ― | 4.50% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €79.5→€81 | ― | 5.10% | Reiterated | ||||
| Compagnie Générale des Établissements Michelin | BUY €38 | ― | -3.00% | Reiterated | Bernstein Keeps Their Buy Rating on Compagnie Générale des Établissements Michelin (MGDDF) | |||
Credit Agricole | SELL €19.5→€18 | ― | -0.70% | Downgraded | Credit Agricole downgraded to Underperform at Keefe Bruyette | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €302→€316 | ― | 11.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €207 | ― | 7.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY ― | ― | 3.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €66→€65 | ― | 1.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €36→€37.5 | ― | 15.00% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €20→€19 | ― | 14.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €19.7→€20 | ― | 3.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €185 | ― | 27.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €60 | ― | 5.00% | Downgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €34.3→€35.7 | ― | 16.90% | Reiterated | ||||
| Clariane | HOLD €3.1→€4.7 | ― | -5.50% | Upgraded | Clariane upgraded to Hold from Reduce at Kepler Cheuvreux | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €35 | ― | 4.50% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €27 | ― | 21.20% | Reiterated | ||||
 | Sartorius Stedim Biotech | BUY €210 | ― | -6.60% | Reiterated | Sartorius Stedim Biotech (0RG8) Gets a Buy from RBC Capital | |||
| Nexans | BUY €185 | ― | -8.10% | Initiated | Nexans re-initiated with an Outperform at BNP Paribas | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €87.5→€88.5 | ― | 1.90% | Downgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €33→€36 | ― | 7.70% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €45 | ― | 3.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY ― | ― | 17.60% | Reiterated | ||||
| JCDecaux SA | BUY €29 | ― | -4.90% | Reiterated | JCDecaux SA (0MGO) Receives a Buy from J.P. Morgan | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €21 | ― | 12.90% | Reiterated | ||||
| JCDecaux SA | HOLD €21→€20.7 | ― | -1.50% | Reiterated | Goldman Sachs Remains a Hold on JCDecaux SA (0MGO) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €50.7 | ― | 18.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €28 | ― | 12.80% | Assigned | ||||
Victoria Chang J.P. MorganNot Ranked | Bureau Veritas | HOLD €30→€29 | ― | ― | Reiterated | Bureau Veritas price target lowered to EUR 29 from EUR 30 at JPMorgan | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €120→€105 | ― | 15.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €105 | ― | 4.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €32 | ― | 11.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €43→€45 | ― | 28.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €38.5 | ― | 14.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €77 | ― | 4.50% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €180 | ― | 19.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €225 | ― | 19.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €88 | ― | 2.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €40.32 | ― | 5.10% | Reiterated | ||||
| Trigano SA | BUY €187 | ― | -6.20% | Reiterated | Analysts Offer Insights on Consumer Cyclical Companies: Trigano SA (Other OTC: TGNOF), Versigent Limited (NYSE: VGNT) and Ball (NYSE: BALL) |
Rows:
